Acute treatment and long-term prognosis of severe protein-loss in atopic dermatitis (splad)
CONCLUSIONS: Even in patients with SPLAD, the most severe AD, TCS-use may be reduced to 2 days per week or less after 3 years with appropriate skin treatment.PMID:34911891 | DOI:10.15036/arerugi.70.1383
Source: Arerugi - Category: Allergy & Immunology Authors: Kenji Toyokuni Kiwako Yamamoto-Hanada Akio Yoshida Yumiko Miyaji Shigenori Kabashima Tatsuki Fukuie Ichiro Nomura Yukihiro Ohya Source Type: research
More News: Allergy | Allergy & Immunology | Child Development | Children | Corticosteroid Therapy | Dermatitis | Dermatology | Milk | Skin | Study | Wheat